Surendra Chaurasia, head of the supply management branch of the health service department, said that 664,650 doses of Pfizer vaccine were received this morning under the COVAX facility.
Surendra Chaurasia, head of the supply management branch of the health service department, said that 664,650 doses of Pfizer vaccine were received this morning under the COVAX facility.
KATHMANDU: The government is administering the Pfizer vaccines against COVID-19 in Nepal from Sunday.
The vaccine is being administered to people with chronic diseases and who are older than 12 years old.
According to Sagar Dahal, chief of the Immunization Section under the Department of Health Service, the Pfizer vaccine, received in a grant from the COVAX facility, will be administered to more than 50,000 people with chronic diseases.
Those receiving the first dose will be administered the second dose within 21 to 28 days of receiving their first dose.
Earlier, Nepal received 100,620 doses of Pfizer COVID-19 vaccines from COVAX.
It has been made mandatory to possess a medical report of chronic disease issued by hospitals or medics to receive the vaccine.
The vaccination drive is being carried out at24 vaccine centers including eight in Kathmandu Valley and 16 out of the valley.
KATHMANDU, November 14: The government is administering the Pfizer vaccines against COVID-19 in Nepal from Sunday.
The vaccine will be administered to people with chronic diseases and who are older than 12 years old.
According to Sagar Dahal, chief of the Immunization Section under the Department of Health Service, the Pfizer vaccine, received in a grant from the COVAX facility, will be administered to more than 50,000 people with chronic diseases.
Those receiving the first dose will be administered the second dose within 21 to 28 days of receiving their first dose.
Earlier, Nepal received 100,620 doses of Pfizer COVID-19 vaccines from COVAX.
It has been made mandatory to possess a medical report of chronic disease issued by hospitals or medics to receive the vaccine.
The vaccination drive will be conducted in 24 vaccine centers including eight in Kathmandu Valley and 16 out of the valley.
Who can receive the vaccine?
1) Those who underwent heart surgery and heart patients
2) Kidney patients
3) Cancer patients
4) Lungs patients
5) Those who underwent any sort of organ transplant
6) High blood pressure and diabetes patients
7) Those with compromised immunity
8) Those suffering from brain diseases
Vaccine centers for Pfizer vaccination in Kathmandu Valley:
1) Bir Hospital
2) TU Teaching Hospital
3) Civil Hospital
4) Sahid Gangalal Hospital
5) Bhaktapur Cancer Hospital
6) Patan Hospital
7) Sahid Dharmabhakta National Transplant Center
8) Birendra Sainik Hospital
Vaccination centers outside of the valley
1) Mechi Hospital
2) BP Koirala Institute of Health Sciences
3) Janakpur Hospital
4) BP Koirala Memorial Cancer Hospital
5) Pokhara Academy of Health Sciences
6) Lumbini Provincial Hospital
7) Bheri Hospital
8) Koshi Hospital
9) Gajendra Narayan Singh Institute of Health Sciences
10) Dadeldhura Hospital
11) Rapti Institute of Health Sciences
12) Karnali Provincial Hospital
13) Seti Hospital
14) Dhulikhel Hospital
15) Dhaulagiri Hospital
16) Narayani Hospital
Possible side effects of Pfizer COVID-19 vaccine
- swelling, pain and redness in arm
- headache, fever and chills
- muscles and joints pain
-loss in appetite and nausea
- tiredness
These symptoms will last only for two to three days after receiving the vaccine, according to the health ministry.
To reduce pain and discomfort where the shot is given, the Center for Disease Control and Prevention of the United States of America recommends:
- Applying a clean, cool, wet washcloth over the area
- Using or exercising your arm
To reduce discomfort from fever
- Drinking plenty of fluids
- Dressing lightly
The 100,620 doses of Pfizer’s Covid-19 vaccine arrived in Kathmandu on Monday. Photos: AMIT MACHAMASI he first 100,620 doses of Pfizer’s Covid-19 vaccine under the global COVAX initiative arrived in Kathmandu on Monday, even as the country’s rate for fully vaccinated population nears 23%. The BioNTech doses, however, will not be administered to children above age 12 […]
The government is set to receive 100,000 doses of Pfizer–BioNTech COVID-19 vaccine to be delivered under the COVAX sharing scheme for poorer countries.
KATHMANDU, September 12: The Pfizer COVID-19 vaccine has been granted approval for emergency use against the novel coronavirus disease (COVID-19) in Nepal.
The Department of Drugs Administrations (DDA) has granted the approval to administer Pfizer COVID-19 vaccines among childrens in Nepal.
“The DDA has granted permission to distribute Pfizer COVID-19 vaccines through the Ministry of Health and Population (MoHP),” said Narayan Prasad Dhakal, Director General of the department. “The government can now procure the Pfizer COVID-19 vaccines and administer it among childrens.”
The government has begun preparations to administer Pfizer COVID-19 vaccines to children who are more than 12 years old.
Nepal is scheduled to receive 100,000 doses of Pfizer COVID-19 vaccines in a few days through the COVAX facility.
So far, along with the Pfizer COVID-19 vaccine, Covishield, Vero Cell, J & J and Astrazeneca vaccines have been given approval for emergency use against COVID-19. (With inputs from Annapurna Post)
